Paula Iruzubieta

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals

Benedetta Donati, Paola Dongiovanni, Stefano Romeo et al. · Scientific Reports · 2017 · 248 citations · Full text

Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation

Lucía Barbier‐Torres, Karen A. Fortner, Paula Iruzubieta et al. · Nature Communications · 2020 · 142 citations · Full text

Lipid Peroxidation, Pathology, Fatty Liver Disease +28

Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry

Camilla Stephens, Mercedes Robles‐Díaz, Inmaculada Medina‐Cáliz et al. · Journal of Hepatology · 2021 · 135 citations · Full text

Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly

Jorge Simón, Maitane Núñez-García, Pablo Fernández‐Tussy et al. · Cell Metabolism · 2020 · 128 citations · Full text

Metabolic Syndrome, Hepatology, Biochemistry +12

Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease

David Martí‐Aguado, José Luís Calleja, Eduardo Vilar‐Gómez et al. · Journal of Hepatology · 2024 · 127 citations · Full text

Pathology, Fatty Liver Disease, Obesity +19